JP Morgan Maintains Neutral on Medtronic, Lowers Price Target to $100
Medtronic Plc +0.14%
Medtronic Plc MDT | 88.12 | +0.14% |
JP Morgan analyst Robbie Marcus maintains Medtronic (NYSE:
MDT) with a Neutral and lowers the price target from $105 to $100.
